Po-Lan Su

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 15

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Lipopolysaccharide Induced

Top Venues

Scientific reports

Thoracic cancer

Journal of clinical medicine

Journal of fungi (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Scientific reports 13 (1) (2023)
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Scientific reports 13 (1) (2023)
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Scientific reports 13 (1) (2023)
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Scientific reports 13 (1) (2023)
Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, Yun-Tse Chou, Chian-Wei Chen, Jeng-Shiuan Tsai, Po-Lan Su, Chien-Chung Lin
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study. Therapeutic advances in medical oncology 15 (2023)
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Scientific reports 13 (1) (2023)
Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, Jeng-Shiuan Tsai, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study. Thoracic cancer (2023)
Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Po-Lan Su, Zhanqi Zhao, Yen-Fen Ko, Chang-Wen Chen, Kuo-Sheng Cheng
Spontaneous Breathing and Pendelluft in Patients with Acute Lung Injury: A Narrative Review. Journal of clinical medicine 11 (24) (2022)
Po-Lan Su, Zhanqi Zhao, Yen-Fen Ko, Chang-Wen Chen, Kuo-Sheng Cheng
Spontaneous Breathing and Pendelluft in Patients with Acute Lung Injury: A Narrative Review. Journal of clinical medicine 11 (24) (2022)
Chi-Jung Wu, Cong-Tat Cia, Hsuan-Chen Wang, Chang-Wen Chen, Wei-Chieh Lin, Jen-Chieh Lee, Po-Sheng Chen, Chih-Cheng Hsieh, Wei-Ting Li, Po-Lan Su, Xin-Min Liao, Ming-I Hsieh, Pui-Ching Choi, Wen-Chien Ko
Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019. Journal of fungi (Basel, Switzerland) 8 (1) (2022)
Po-Lan Su, Zhanqi Zhao, Yen-Fen Ko, Chang-Wen Chen, Kuo-Sheng Cheng
Spontaneous Breathing and Pendelluft in Patients with Acute Lung Injury: A Narrative Review. Journal of clinical medicine 11 (24) (2022)
Chung-Fu Lin, Szu-Yu Liu, Tzu-Kun Lo, Julia Yu-Yun Lee, Po-Lan Su
Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report. Thoracic cancer 13 (3) (2021)
Chi-Hao Wu, Po-Lan Su, Che-Wei Hsu, Chang-Yao Chu, Chien-Chung Lin
Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report. Thoracic cancer 12 (22) (2021)
Sheng-Yuan Wang, Ching-Han Lai, Chian-Wei Chen, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors. Thoracic cancer (2021)